Clinical Trial

A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants

Name: A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants — clinical trial record (NCT07577479)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Protocol Amendment History 2 changes

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-25

critical Recruitment opened 2026-06-05

Trial Details

NCT Number	NCT07577479
Lead Sponsor	Shanghai Argo Biopharmaceutical Co., Ltd.
Conditions	Healthy Participants Study
Enrollment	24 participants
Start Date	2026-05-18
Primary Completion	2027-06-30 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-24